Stay updated on Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Sign up to get notified when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.

Latest updates to the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page
- Check7 days agoChange DetectedNew revision tag v3.5.4 appears, replacing the previous v3.5.3. This indicates a minor backend/metadata update to the page, with no observable changes to study details, eligibility criteria, or study results.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s displayed revision version was updated from v3.5.2 to v3.5.3, indicating a maintenance/version change rather than an update to the clinical trial information.SummaryDifference0.0%

- Check35 days agoChange DetectedPatch-level revision update was applied to the page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check100 days agoChange DetectedAdded a Tuberculosis entry under Resources and linked to the Genetic and Rare Diseases Information Center. Updated the revision tag from v3.4.1 to v3.4.2.SummaryDifference0.2%

Stay in the know with updates to Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.